Denny Xu

Associate
Full contact info

Experience

MaxCyte – $202 Million IPO

July 30, 2021

Cooley advised MaxCyte on its $201.8 million initial public offering of 15,525,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. MaxCyte, whose securities now trade on the Nasdaq Global Select Market under the symbol “MXCT,” also trades on the London Stock Exchange under the symbols "MXCT" and "MXCN." MaxCyte is a leading provider of cell-engineering platform technologies. Partners Christian Plaza, Brian Leaf and Claire Keast-Butler led the Cooley team.

Related contacts

Christian Plaza
Partner, Reston
Brian Leaf
Partner, Reston
Claire Keast-Butler
Partner, London
Katie Kazem
Partner, Reston
Paul Alexander
Associate, Washington, DC
Moussa O. Ismail
Associate, Reston
Div Gupta
Partner, New York
Brent Siler
Senior Counsel, Washington, DC
Madison Jones
Partner, Washington, DC
Denny Xu
Associate, Boston

Related Practices & Industries

Verve Therapeutics – $307 Million IPO

June 17, 2021

Cooley advised the underwriters on Verve Therapeutics’ $306.7 million initial public offering of 16,141,157 shares of common stock. J.P. Morgan, Jefferies, Guggenheim Securities and William Blair acted as joint book-running managers for the offering. Verve Therapeutics, whose securities now trade on the Nasdaq Global Select Market under the symbol VERV, is a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene-editing medicines. Partners Brent Siler, Div Gupta and Richard Segal led the Cooley team.

Related contacts

Brent Siler
Senior Counsel, Washington, DC
Div Gupta
Partner, New York
Richard Segal
Partner, New York
Darah Protas
Partner, Washington, DC
Denny Xu
Associate, Boston

Related Practices & Industries

Talaris Therapeutics – $150 Million IPO

May 6, 2021

Cooley advised the underwriters on Talaris Therapeutics' $150 million initial public offering of 8,825,000 shares of common stock. Morgan Stanley, SVB Leerink, Evercore Groupand Guggenheim Securitiesacted as joint book-running managers for the offering. Talaris Therapeutics, whose securities now trade on the Nasdaq Global Select Market under the symbol TALS, is a late-clinical stage, cell therapy company developing an innovative method of allogeneic hematopoietic stem cell transplantation. Partners Richard Segal, Marc Recht and Div Gupta led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Marc Recht
Partner, Boston
Div Gupta
Partner, New York
Denny Xu
Associate, Boston

Related Practices & Industries

Werewolf Therapeutics – $120 Million IPO

April 30, 2021

Cooley advised the underwriters on Werewolf Therapeutics’ $120 million initial public offering of 7,500,000 shares of common stock. Jefferies, SVB Leerink and Evercore Group acted as joint book-running managers. Werewolf Therapeutics, whose securities now trade on the Nasdaq Global Select Market under the symbol HOWL, is an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. Partners Brent Siler, Madison Jones and Div Gupta led the Cooley team.

Related contacts

Brent Siler
Senior Counsel, Washington, DC
Madison Jones
Partner, Washington, DC
Div Gupta
Partner, New York
Denny Xu
Associate, Boston

Related Practices & Industries

Archer to Combine With SPAC Atlas Crest Investment

March 10, 2021

Cooley advised Archer, a leader in the urban air mobility space, on its agreement to combine with special purpose acquisition company Atlas Crest Investment. Estimated to have an implied $3.8 billion pro forma equity value, the combined company will list on the New York Stock Exchange under the symbol “ACHR.” Partners Dave Peinsipp, John McKenna and Al Browne led the Cooley team advising Archer on the transaction, which is expected to close in Q2.

Read more

Related contacts

David Peinsipp
Partner, San Francisco
John McKenna
Partner, Palo Alto
Alfred Browne
Partner, Boston
Barbara Mirza
Partner, Los Angeles Santa Monica
Todd Gluth
Partner, San Diego
Michael McGrail
Partner, Boston
Thomas Connors
Partner, Boston
Jacqueline Grise
Partner, Washington, DC
Heather Harrington
Special Counsel, Boston
Jesse Schulman
Associate, Washington, DC
Tara Capsuto
Associate, San Francisco
Megan Coneeny
Associate, Boston
Denny Xu
Associate, Boston
Julia R. Brinton
Associate, Washington, DC
David Dalton
Associate, Los Angeles Santa Monica

Related Practices & Industries